The comprehensive assessment of the prevalence of metabolic syndrome in obese children and adolescents

Maiia Aliusef; Alina Churylina

doi:10.32345/USMYJ.4(142).2023.121-128

Maiia Aliusef Department of Pediatrics, Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0001-8271-9614
Alina Churylina Department of Pediatrics, Bogomolets National Medical University, Kyiv, Ukraine https://orcid.org/0000-0003-3130-2178

DOI: https://doi.org/10.32345/USMYJ.4(142).2023.121-128

Keywords: Body Mass Index, Insulin Resistance, Metabolic Syndrome, Paediatric Obesity, Waist Circumference

Abstract

childhood obesity is recognized as a significant health concern by the WHO, but not all obese individuals face the same risk of cardiometabolic disorders. This study aims to diagnose metabolic syndrome (MetS) in obese children according to various known definitions and to determine the influence of all five definitions of MetS on insulin resistance using logistic regression models. The observational cross-sectional study on 82 children aged 12 to 17 with obesity was conducted at the Children’s Clinical Hospital No.6 in Kyiv. MetS was established according to five main definitions. All biochemical analyses were performed using the enzymatic colorimetric method by Cobas 6000, Roche Diagnostics (Switzerland). The prevalence of MetS among children with obesity was higher using the de Ferranti et al. (76.8%) definition and the lower using Viner et al. definition (29.3%), p=0.023. The construction of a logistic regression model showed that having all the components of MetS according to different definitions, children and adolescents are likely to have a HOMA-2 above 2.26 (AUC more significant than 0.5, p<0.05). Different prevalence of MetS was found, depending on the different approaches to diagnosis. The construction of a logistic regression model showed that the parameters of the metabolic syndrome influence the risk of high HOMA-2 IR using four of five definitions.

References

Aguilar-Gomez F, Bueno-Lozano G, Leis R et al. Metabolic syndrome before puberty: Myth or reality?, Current Opinion in Endocrine and Metabolic Research, https://doi.org/10.1016/j.coemr.2020.06.006.

Al-Beltagi, M., Bediwy, A. S., & Saeed, N. K. (2022). Insulin-resistance in paediatric age: Its magnitude and implications. World journal of diabetes, 13(4), 282–307. https://doi.org/10.4239/wjd.v13.i4.282

Aliusef, M. H., Gnyloskurenko, G. V., Churylina, A. V. et al. (2022). Clustering patterns of metabolic syndrome: A cross-sectional study in children and adolescents in Kyiv. Frontiers in pediatrics, 10, 972975. https://doi.org/10.3389/fped.2022.972975

Brady, T. M., Stefani-Glücksberg, A., & Simonetti, G. D. (2019). Management of high blood pressure in children: similarities and differences between US and European guidelines. Pediatric nephrology (Berlin, Germany), 34(3), 405–412. https://doi.org/10.1007/s00467-018-3946-y

Centers for Disease Control and Prevention. (2022, December 15). Growth charts - CDC extended BMI-for-age growth charts. Centers for Disease Control and Prevention. https://www.cdc.gov/growthcharts/extended-bmi.htm

DeBoer M. D. (2019). Assessing and Managing the Metabolic Syndrome in Children and Adolescents. Nutrients, 11(8), 1788. https://doi.org/10.3390/nu11081788).

Drozdz, D., Alvarez-Pitti, J., Wójcik, M. et al. (2021). Obesity and Cardiometabolic Risk Factors: From Childhood to Adulthood. Nutrients, 13(11), 4176. https://doi.org/10.3390/nu13114176

Fernández-Aparicio, Á., Perona, J. S., Schmidt-RioValle, J. et al. (2021). Concordance among diagnostic criteria for metabolic syndrome is inconsistent in Spanish adolescents. European journal of clinical investigation, 51(2), e13384. https://doi.org/10.1111/eci.13384

Jaswal, V., & Kishore, K. (2021). Statistics corner: Introduction to R and R commander (rcmdr). Journal of Postgraduate Medicine, Education and Research, 55(4), 192–196. https://doi.org/10.5005/jp-journals-10028-1453

Jebeile, H., Kelly, A. S., O'Malley, G. et al. (2022). Obesity in children and adolescents: epidemiology, causes, assessment, and management. The lancet. Diabetes & endocrinology, 10(5), 351–365. https://doi.org/10.1016/S2213-8587(22)00047-X

Lim, Y., & Boster, J. (2023). Obesity and Comorbid Conditions. In StatPearls. StatPearls Publishing.

Littleton, S. H., Berkowitz, R. I., & Grant, S. F. A. (2020). Genetic Determinants of Childhood Obesity. Molecular diagnosis & therapy, 24(6), 653–663. https://doi.org/10.1007/s40291-020-00496-1

Lobstein T, Brinsden H. Global Atlas on Childhood Obesity. World Obesity Federation. 2019. [Last accessed on 01 Dec 2022]. Available from: https://www.worldobesity.org/membersarea/global-atlas-on-childhood-obesity.

Reisinger, C., Nkeh-Chungag, B.N., Fredriksen, P.M. et al. The prevalence of pediatric metabolic syndrome—a critical look on the discrepancies between definitions and its clinical importance. Int J Obes 45, 12–24 (2021). https://doi.org/10.1038/s41366-020-00713-1

Rigamonti, A. E., Frigerio, G., Caroli, D. et al. (2023). A Metabolomics-Based Investigation of the Effects of a Short-Term Body Weight Reduction Program in a Cohort of Adolescents with Obesity: A Prospective Interventional Clinical Study. Nutrients, 15(3), 529. https://doi.org/10.3390/nu15030529

Sanin, V., Schmieder, R., Ates, S. et al. (2022). Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study. European journal of public health, 32(3), 422–428. https://doi.org/10.1093/eurpub/ckac007.

Smith, G. I., Mittendorfer, B., & Klein, S. (2019). Metabolically healthy obesity: facts and fantasies. The Journal of clinical investigation, 129(10), 3978–3989. https://doi.org/10.1172/JCI129186

World Health Organization (2021, June 9). Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight